FDA Investigator Daniel L Zheng
Daniel L Zheng has inspections in 1 countries as of 06 Oct 2023. Daniel L Zheng has collaborated with a combined 1754 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
17
Last Inspection Date:
06 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alan R Condon,
Alice S Tsao,
Amber G Wardwell,
Amy C Jordan,
Amy M Cramer,
Andrew M Abramowitz,
Andrew M Barlow,
Anthony C Warchut,
Bijoy Panicker,
Brandy N Lepage,
Carl A Perez,
Cassandra L Abellard,
Charisse K Green,
Constance Desimone,
Daryl A Dewoskin,
David A Oluwo,
Dorothy W Lee,
Dr. Robert C Horan, MD,
Dr. Yubing Tang,
Edmund F Mrak, Jr,
Erik W Koester,
Felix Maldonado,
Frederick Razzaghi,
Gary J Lehr,
Gary T Greco,
George T Allen, Jr,
Gerard D Difiore,
Helen B Ricalde,
Jacqueline Mdiaz Albertini,
James A Liubicich,
James Norman,
Jawaid Hamid,
Jay T Wong,
Jianming Li,
Jie He,
Joan A Loreng,
John P Mistler,
John R Carlson,
Jonathan G Matrisciano,
Jose O Hernandez,
Justine M Corson,
Kalavati Suvarna, PhD,
Karen Mcnabb Noon,
Kenneth H Williams,
Kevin A Gonzalez,
Kim Lthomas Cruse,
Laura L Staples,
Lauren N Barber,
Laurie B Frazier,
Lawrence W Farina,
Leanna M Slarsky,
Lori M Newman,
Margaret E Walsh,
Margaret M Sands,
Marie Bbuen Bigornia,
Mark C Lookabaugh,
Mary Jeanet Mcgarry,
Maya M Davis,
Megan A Haggerty,
Meredith P Soehl, Investigator,
Michael Serrano,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Mindy M Chou,
Nariman Patenaude,
Nazmul Hassan,
Nealie C Newberger,
Nicola M Fenty Stewart,
Obinna R Echeozo,
Paraluman S Leonin,
Parul M Patel,
Paul L Bellamy,
Paula M Laplant,
Peter Abel,
Rajiv R Srivastava,
Ramon E Martinez,
Richard H Penta,
Robert C Steyert,
Robert J Martin,
Rory K Geyer,
Samina S Khan,
Sean R Marcsisin,
Shari L Kahn,
Sony Mathews,
Srinivas R Chennamaneni, PhD,
Stacey S Degarmo,
Stephen C Smith,
Stephen R Souza,
Terry Bridgewater,
Thomas J Arista,
Thomas J Mooney,
Uduak M Inokon,
Uttaniti Limchumroon (Tom),
Wayne E Seifert,
William J Leonard,
Yaodong Huang,
Ying Xin Fan, PhD,
Yvesna C Blaise,
Yvonne Y Wu
Daniel L Zheng's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more